BRICS Active Pharmaceutical Ingredient Market (API Type - Chemical API, and Biological API; Drug Type - Generic Prescription Drugs, and OTC Prescription Drugs; Application - Cardiovascular Disease, Oncology, CNS and Neurological Disorders, Orthopedic Disorders, Endocrinology, Gastrointestinal Disorders, Ophthalmology, Pulmonology, and Others): BRICS Industry Analysis, Trends, Size, Share and Forecasts to 2027

1.      Preface

1.1.   Report Description

1.2.   Research Methods

1.3.   Research Approaches

2.      Executive Summary

2.1.   Active Pharmaceuical Ingredient Market Highlights

2.2.   Active Pharmaceuical Ingredient Market Projection

2.3.   Active Pharmaceuical Ingredient Market Country Highlights

3.      BRICS Active Pharmaceuical Ingredient Market Overview

3.1.   Introduction

3.2.   Market Dynamics

3.2.1.Drivers

3.2.2.Restraints

3.2.3.Opportunities

3.3.   Analysis of COVID-19 impact on the Brics Active Pharmaceuical Ingredient Market

3.4.   Porter's Five Forces Analysis

3.5.   IGR-Growth Matrix Analysis

3.5.1.IGR-Growth Matrix Analysis by API Type

3.5.2.IGR-Growth Matrix Analysis by Drug Type

3.5.3.IGR-Growth Matrix Analysis by Application

3.5.4.IGR-Growth Matrix Analysis by Country

3.6.   Value Chain Analysis of Brics Active Pharmaceuical Ingredient Market

4.      BRICS Active Pharmaceuical Ingredient Market by API Type

4.1.   Chemical API

4.2.   Biological API

5.      BRICS Active Pharmaceuical Ingredient Market by Drug Type

5.1.   Generic Prescription Drugs

5.2.   OTC Prescription Drugs

6.      BRICS Active Pharmaceuical Ingredient Market by Application

6.1.   Cardiovascular Disease

6.2.   Oncology

6.3.   CNS and Neurological Disorders

6.4.   Orthopedic Disorders

6.5.   Endocrinology

6.6.   Gastrointestinal Disorders

6.7.   Ophthalmology

6.8.   Pulmonology

6.9.   Others

7.      BRICS Active Pharmaceuical Ingredient Market by Country 2021-2027

7.1.   Brazil

7.1.1.Brazil Active Pharmaceuical Ingredient Market by API Type

7.1.2.Brazil Active Pharmaceuical Ingredient Market by Drug Type

7.1.3.Brazil Active Pharmaceuical Ingredient Market by Application

7.1.4.Brazil Active Pharmaceuical Ingredient Market by Country

7.2.   Russia

7.2.1.Russia Active Pharmaceuical Ingredient Market by API Type

7.2.2.Russia Active Pharmaceuical Ingredient Market by Drug Type

7.2.3.Russia Active Pharmaceuical Ingredient Market by Application

7.2.4.Russia Active Pharmaceuical Ingredient Market by Country

7.3.   India

7.3.1.India Active Pharmaceuical Ingredient Market by API Type

7.3.2.India Active Pharmaceuical Ingredient Market by Drug Type

7.3.3.India Active Pharmaceuical Ingredient Market by Application

7.3.4.India Active Pharmaceuical Ingredient Market by Country

7.4.   China

7.4.1.China Active Pharmaceuical Ingredient Market by API Type

7.4.2.China Active Pharmaceuical Ingredient Market by Drug Type

7.4.3.China Active Pharmaceuical Ingredient Market by Application

7.4.4.China Active Pharmaceuical Ingredient Market by Country

7.5.   South Africa

7.5.1.South Africa Active Pharmaceuical Ingredient Market by API Type

7.5.2.South Africa Active Pharmaceuical Ingredient Market by Drug Type

7.5.3.South Africa Active Pharmaceuical Ingredient Market by Application

7.5.4.South Africa Active Pharmaceuical Ingredient Market by Country

8.      Company Profiles and Competitive Landscape

8.1.   Competitive Landscape in the BRICS Active Pharmaceuical Ingredient Market

8.2.   Companies Profiles

8.2.1.Divi's Laboratories Limited

8.2.2.Nanjing Pharmaceutical Factory Co. Ltd.

8.2.3.Blanver EN

8.2.4.Active Component JSC

8.2.5.Taj Ando Pharmaceuticals

8.2.6.Zhejiang Hisun Pharmaceutical Co. Ltd.

8.2.7.Baltpharma

8.2.8.Granules India Limited

8.2.9.Libbs Farmaceutica Ltda